Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 241-250 of 271 for Lung cancer

Edit search filters
  1. A Study Of Patients Undergoing Neoadjuvant Therapy For Resectable Non-small Cell Lung Cancer To Evaluate Perioperative Circulating Tumor DNA As A Prognostic Biomarker

    Jacksonville, FL

  2. A Study To Evaluate Brigatinib Before Brain Irradiation

    Rochester, MN

  3. Pre-Transplant Patients’ Experiences with Uncertainty

    Jacksonville, FL, Rochester, MN

  4. A Phase 2, Multicenter, Randomized Study Of AP26113

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Testing Proton Craniospinal Radiation Therapy Versus The Usual Radiation Therapy For Leptomeningeal Metastasis, RADIATE-LM Trial

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Phase 2 Trial Of Adagrasib Monotherapy And In Combination With Pembrolizumab And A Phase 3 Trial Of Adagrasib In Combination In Patients With A KRAS G12C Mutation KRYSTAL-7

    Jacksonville, FL, Rochester, MN

  7. Breath Condensate Of Lung Cancer Patients And Healthy Controls To Measure RNA Species In Exhaled Breath Condensate

    Rochester, MN

  8. Identification Of A Plasma Proteomic Signature For Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Study Of RYZ101 In Combination With SoC In Subjects With SSTR+ ES-SCLC

    Jacksonville, FL, Rochester, MN

  10. A Study To Assess DNA Tumor Markers In Whole Blood Specimens Of Patients With Newly Diagnosed Lung Cancer

    Rochester, MN

.

Mayo Clinic Footer